Abbott Labs' Upcoming FDA Audit Is Final Hurdle Of Consent Decree
This article was originally published in The Gray Sheet
An FDA inspection of Abbott Labs' Lake County, Illinois diagnostics manufacturing facility, anticipated in late August or early September, will last two to four weeks, the firm predicts.
You may also be interested in...
Abbott Laboratories' AFP and CA 125 diagnostic cancer tests are among the diagnostic products deemed "medically necessary" by FDA and will continue to be made available under the company's Nov. 2 consent decree with the agency.
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.